Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fainstein

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|February 1, 1994
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancerK V Rolston, H Nguyen, G Amos, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patientsV Fainstein, G P Bodey, L Elting, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem/cilastatin as secondary therapy for infections in cancer patientsG P Bodey, K Rolston, P Jones, et al.
Archives of Internal Medicine|July 1, 1986
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillinP G Jones, S V Strother, K V Rolston, et al.
Medicine|March 1, 1988
The emerging role of Fusarium infections in patients with cancerE Anaissie, H Kantarjian, J Ro, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsL Jadeja, R Bolivar, V Fainstein, et al.
The American Journal of Medicine|June 1, 1987
Pseudomonas putida. Newly recognized pathogen in patients with cancerE Anaissie, V Fainstein, P Miller, et al.
Archives of Internal Medicine|September 1, 1984
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patientsV Fainstein, G P Bodey, R Bolivar, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1984
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin BR L Hopfer, K Mills, R Mehta, et al.
The New England Journal of Medicine|April 21, 1983
Cryptosporidial cholecystitisS D Pitlik, V Fainstein, A Rios, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|February 1, 1994
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancerK V Rolston, H Nguyen, G Amos, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1987
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patientsV Fainstein, G P Bodey, L Elting, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem/cilastatin as secondary therapy for infections in cancer patientsG P Bodey, K Rolston, P Jones, et al.
Archives of Internal Medicine|July 1, 1986
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillinP G Jones, S V Strother, K V Rolston, et al.
Medicine|March 1, 1988
The emerging role of Fusarium infections in patients with cancerE Anaissie, H Kantarjian, J Ro, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsL Jadeja, R Bolivar, V Fainstein, et al.
The American Journal of Medicine|June 1, 1987
Pseudomonas putida. Newly recognized pathogen in patients with cancerE Anaissie, V Fainstein, P Miller, et al.
Archives of Internal Medicine|September 1, 1984
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patientsV Fainstein, G P Bodey, R Bolivar, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1984
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin BR L Hopfer, K Mills, R Mehta, et al.
The New England Journal of Medicine|April 21, 1983
Cryptosporidial cholecystitisS D Pitlik, V Fainstein, A Rios, et al.
Pageof 12